ARAV

Aravive Inc
2.25
-0.21 (-8.54%)

Period:

Draw Mode:

Volume 753,521
Bid Price 2.25
Ask Price 2.40
News -
Day High 2.4599

Low
0.5801

52 Week Range

High
2.46

Day Low 2.22
Company Name Stock Ticker Symbol Market Type
Aravive Inc ARAV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.21 -8.54% 2.25 19:49:57
Open Price Low Price High Price Close Price Prev Close
2.41 2.22 2.4599 2.25 2.46
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,682 753,521 $ 2.32 $ 1,746,025 - 0.5801 - 2.46
Last Trade Time Type Quantity Stock Price Currency
19:59:01 705 $ 2.24 USD

Aravive Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 134.65M 59.84M 5.20M $ 9.14M $ - -2.12 5.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.90M 9.40%

more financials information »

Aravive News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARAV Message Board. Create One! See More Posts on ARAV Message Board See More Message Board Posts

Historical ARAV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.662.461.602.07773,5630.5935.54%
1 Month1.852.461.601.98484,8580.4021.62%
3 Months1.212.461.20681.93260,1521.0485.95%
6 Months0.932.460.74191.71438,4551.32141.94%
1 Year1.922.460.58011.58272,2750.3317.19%
3 Years3.6514.940.58014.52229,147-1.40-38.36%
5 Years6.5229.600.58015.55197,041-4.27-65.49%

Aravive Description

Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. Aravive's lead candidate is batiraxcept, which is is an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway.